Non-alcoholic fatty liver disease: a massive problem

被引：98
作者：
Day, Christopher P. [1 ]
机构：
[1] Newcastle Univ, Fac Off, Fac Med Sci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
CLINICAL MEDICINE | 2011年 / 11卷 / 02期
关键词：
fatty liver; insulin resistance; obesity; steatohepatitis; steatosis; CONTROLLED-TRIAL; VITAMIN-E; CIRRHOSIS; PLACEBO; NAFLD;
D O I：
10.7861/clinmedicine.11-2-176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：176 / 178
页数：3
相关论文
共 18 条
[1]   Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis [J].
Argo, Curtis K. ;
Northup, Patrick G. ;
Al-Osaimi, Abdullah M. S. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2009, 51 (02) :371-379
[2]   Statins and hepatic steatosis: Perspectives from the Dallas Heart Study [J].
Browning, Jeffrey D. .
HEPATOLOGY, 2006, 44 (02) :466-471
[3]   Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis [J].
Contos, MJ ;
Cales, W ;
Sterling, RK ;
Luketic, VA ;
Shiffman, ML ;
Mills, AS ;
Fisher, RA ;
Ham, J ;
Sanyal, AJ .
LIVER TRANSPLANTATION, 2001, 7 (04) :363-373
[4]   From fat to inflammation [J].
Day, CP .
GASTROENTEROLOGY, 2006, 130 (01) :207-210
[5]   Current and Future Therapeutic Strategies in NAFLD [J].
de Alwis, Nimantha Mark Wilfred ;
Day, Christopher Paul .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (17) :1958-1962
[6]   Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis [J].
Dufour, Jean-Francois ;
Oneta, Carl M. ;
Gonvers, Jean-Jacques ;
Bihl, Florian ;
Cerny, Andreas ;
Cereda, Jean-Michel ;
Zala, Jean-Franco ;
Helbling, Beat ;
Steuerwald, Michael ;
Zimmermann, Arthur .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (12) :1537-1543
[7]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873
[8]   Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study [J].
Feldstein, Ariel E. ;
Wieckowska, Anna ;
Lopez, A. Rocio ;
Liu, Yao-Chang ;
Zein, Nizar N. ;
McCullough, Arthur J. .
HEPATOLOGY, 2009, 50 (04) :1072-1078
[9]   Hepatic histology in obese patients undergoing bariatric surgery [J].
Machado, Mariana ;
Marques-Vidal, Pedro ;
Cortez-Pinto, Helena .
JOURNAL OF HEPATOLOGY, 2006, 45 (04) :600-606
[10]   Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance [J].
Newton, J. L. ;
Jones, D. E. J. ;
Henderson, E. ;
Kane, L. ;
Wilton, K. ;
Burt, A. D. ;
Day, C. P. .
GUT, 2008, 57 (06) :807-813
12